Impulse Dynamics announced today that it raised more than $158 million in financing to support its heart failure treatment ...

After securing Medicare reimbursement for its pacemaker-like heart failure (HF) implant, Impulse Dynamics has raised more ...

Please provide your email address to receive an email when new articles are posted on . Impulse Dynamics announced it received FDA and CE Mark approval and launched its miniature next-generation ...

The implantable Optimizer device delivers non-excitatory Cardiac Contractility Modulation signals to the heart muscle, and initiates multiple biochemical and neurohormonal changes to the myocardium.

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--Impulse Dynamics, developer of the implantable Optimizer Smart System for delivering CCM™ (Cardiac Contractility Modulation) therapy, announced today that it has ...

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--Impulse Dynamics, developer of Optimizer ® Smart System for delivering CCM™ therapy, announced the completion of an $80.25 million Series D financing with new ...

BOSTON — In patients with HF with reduced ejection fraction, cardiac contractility modulation improved exercise tolerance and quality of life and reduced hospitalizations for HF, according to findings ...

The U.S. Centers for Medicare & Medicaid Services (CMS) has issued a draft coverage memo for cardiac contractility modulation (CCM), which offers coverage with evidence development for the company’s ...

The backlog of requests for Medicare national coverage analyses is a matter of record, but a new analysis highlights how deep that backlog runs. CMS declared it will review a petition from Impulse ...